119 related articles for article (PubMed ID: 1106447)
1. [Pharmacokinetic studies on absorption and excretion of oxazepam in Combination with alcohol (author's transl)].
Mallach HJ; Moosmayer A; Gottwald K; Staak M
Arzneimittelforschung; 1975 Nov; 25(11):1840-5. PubMed ID: 1106447
[TBL] [Abstract][Full Text] [Related]
2. Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection.
Knowles JA; Ruelius HW
Arzneimittelforschung; 1972 Apr; 22(4):687-92. PubMed ID: 5068248
[No Abstract] [Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of oxazepam: absence of influence of food intake.
Melander A; Danielson K; Vessman J; Wählin E
Acta Pharmacol Toxicol (Copenh); 1977 May; 40(5):584-8. PubMed ID: 577372
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic studies after oral administration of oxazepam in combination with alcohol].
Moosmayer A; Mallach HJ; Staak M
Beitr Gerichtl Med; 1976; 34():85-9. PubMed ID: 971253
[No Abstract] [Full Text] [Related]
6. [Psychopharmacological studies on the interactions between alcohol and oxazepam with regard to reaction behavior. 1st communication. Changes of psychomotor coordination and reaction behavior].
Staak M; Gottwald K; Mallach HJ; Schubring G
Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):48-65. PubMed ID: 977201
[TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacologic studies on the combined effect of alcohol and oxazepam on reactivity pattern. II. Subjective feeling and reaction behavior].
Staak M; Gottwald K; Mallach HJ; Schubring G
Int J Clin Pharmacol Biopharm; 1977 May; 15(5):234-44. PubMed ID: 326690
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic studies on interactions between dipotassium clorazepate and alcohol after oral application (author's transl)].
Staak M; Moosmayer A
Arzneimittelforschung; 1978; 28(7):1187-91. PubMed ID: 39573
[TBL] [Abstract][Full Text] [Related]
9. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
10. [Alcohol absorption and elimination in different alimentary conditions (author's transl)].
Weinel H; Kruse-Jarres JD
Arzneimittelforschung; 1975 Oct; 25(10):1655-9. PubMed ID: 1243053
[TBL] [Abstract][Full Text] [Related]
11. The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one) in man, miniature swine and rat.
Sisenwine SF; Tio CO; Shrader SR; Ruelius HW
Arzneimittelforschung; 1972 Apr; 22(4):682-7. PubMed ID: 5068247
[No Abstract] [Full Text] [Related]
12. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ
J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915
[TBL] [Abstract][Full Text] [Related]
13. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic studies after oral and parenteral application of dipotassium chlorazepate (author's transl)].
Staak M; Moosmayer A; Besserer K; Speidel K; Kleinschmidt A
Arzneimittelforschung; 1982; 32(3):272-5. PubMed ID: 6123331
[TBL] [Abstract][Full Text] [Related]
15. [Does oxazepam (ADUMBRAN) interfere with anticoagulant treatment. A controlled study. (author's transl)].
Schneider J; Kamm G
Med Klin; 1978 Feb; 73(5):153-6. PubMed ID: 622064
[TBL] [Abstract][Full Text] [Related]
16. [Studies of the metabolism of 7-chlor-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on].
Steidinger J; Schmid E
Arzneimittelforschung; 1970 Sep; 20(9):1232-5. PubMed ID: 5536799
[No Abstract] [Full Text] [Related]
17. Metabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice.
Griffin RJ; Burka LT
Drug Metab Dispos; 1993; 21(5):918-26. PubMed ID: 7902256
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Oct; 468():1-189. PubMed ID: 12579205
[TBL] [Abstract][Full Text] [Related]
19. A double-blind cross-over evaluation of the activity of d-oxazepam hemisuccinate sodium salt (D-7-chloro-1,3-dihydro-3-hemisuccinyloxy-5-phenyl-2H-1,4-benzodiazepine-2-one) compared to its racemic form.
Lescovelli M; Castellani A; Perbellini D
Arzneimittelforschung; 1976; 26(8):1623-6. PubMed ID: 795440
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
